PDB Short entry for 3JUH HEADER TRANSFERASE 15-SEP-09 3JUH TITLE CRYSTAL STRUCTURE OF A MUTANT OF HUMAN PROTEIN KINASE CK2ALPHA WITH TITLE 2 ALTERED COSUBSTRATE SPECIFICITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-335; COMPND 5 SYNONYM: CK II; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT7-7 KEYWDS EUKARYOTIC PROTEIN KINASE, ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, KEYWDS 2 PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, WNT KEYWDS 3 SIGNALING PATHWAY EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,O.-G.ISSINGER REVDAT 4 20-MAR-24 3JUH 1 REMARK SEQADV REVDAT 3 26-OCT-11 3JUH 1 JRNL REMARK VERSN REVDAT 2 22-JUN-11 3JUH 1 REMARK TITLE REVDAT 1 20-OCT-09 3JUH 0 SPRSDE 20-OCT-09 3JUH 3BW5 JRNL AUTH C.W.YDE,I.ERMAKOVA,O.-G.ISSINGER,K.NIEFIND JRNL TITL INCLINING THE PURINE BASE BINDING PLANE IN PROTEIN KINASE JRNL TITL 2 CK2 BY EXCHANGING THE FLANKING SIDE-CHAINS GENERATES A JRNL TITL 3 PREFERENCE FOR ATP AS A COSUBSTRATE JRNL REF J.MOL.BIOL. V. 347 399 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 15740749 JRNL DOI 10.1016/J.JMB.2005.01.003 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.RAAF,E.BRUNSTEIN,O.-G.ISSINGER,K.NIEFIND REMARK 1 TITL THE CK2 ALPHA/CK2 BETA INTERFACE OF HUMAN PROTEIN KINASE CK2 REMARK 1 TITL 2 HARBORS A BINDING POCKET FOR SMALL MOLECULES REMARK 1 REF CHEM.BIOL. V. 15 111 2008 REMARK 1 REFN ISSN 1074-5521 REMARK 1 PMID 18291315 REMARK 1 DOI 10.1016/J.CHEMBIOL.2007.12.012 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.NIEFIND,O.-G.ISSINGER REMARK 1 TITL CONFORMATIONAL PLASTICITY OF THE CATALYTIC SUBUNIT OF REMARK 1 TITL 2 PROTEIN KINASE CK2 AND ITS CONSEQUENCES FOR REGULATION AND REMARK 1 TITL 3 DRUG DESIGN REMARK 1 REF BIOCHIM.BIOPHYS.ACTA V.1804 484 2010 REMARK 1 REFN ISSN 0006-3002 REMARK 1 PMID 19796713 REMARK 1 DOI 10.1016/J.BBAPAP.2009.09.022 REMARK 1 REFERENCE 3 REMARK 1 AUTH K.NIEFIND,J.RAAF,O.-G.ISSINGER REMARK 1 TITL PROTEIN KINASE CK2 IN HEALTH AND DISEASE: PROTEIN KINASE REMARK 1 TITL 2 CK2: FROM STRUCTURES TO INSIGHTS REMARK 1 REF CELL.MOL.LIFE SCI. V. 66 1800 2009 REMARK 1 REFN ISSN 1420-682X REMARK 1 PMID 19387553 REMARK 1 DOI 10.1007/S00018-009-9149-8 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 70535 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.158 REMARK 3 R VALUE (WORKING SET) : 0.156 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2239 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.66 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.70 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4314 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.76 REMARK 3 BIN R VALUE (WORKING SET) : 0.2160 REMARK 3 BIN FREE R VALUE SET COUNT : 144 REMARK 3 BIN FREE R VALUE : 0.3450 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5630 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 518 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.32000 REMARK 3 B22 (A**2) : -3.32000 REMARK 3 B33 (A**2) : 6.64000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.021 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.024 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.065 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.569 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.973 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.956 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5946 ; 0.024 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4143 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8063 ; 2.148 ; 1.962 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9992 ; 1.120 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 686 ; 7.369 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 317 ;35.971 ;23.060 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1049 ;17.439 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 53 ;23.420 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 831 ; 0.130 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6570 ; 0.011 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1311 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 34038 ; 0.018 ; 0.200 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 65374 ; 0.015 ; 0.200 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.500 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : -H, K, -L REMARK 3 TWIN FRACTION : 0.500 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 339 A 339 REMARK 3 ORIGIN FOR THE GROUP (A): -38.3540 89.4330 13.8660 REMARK 3 T TENSOR REMARK 3 T11: 0.3491 T22: 0.3742 REMARK 3 T33: 0.3063 T12: -0.0333 REMARK 3 T13: -0.0253 T23: 0.0828 REMARK 3 L TENSOR REMARK 3 L11: 0.0806 L22: 8.7868 REMARK 3 L33: 0.0336 L12: 0.8166 REMARK 3 L13: 0.0333 L23: 0.3946 REMARK 3 S TENSOR REMARK 3 S11: 0.0702 S12: -0.0210 S13: -0.1043 REMARK 3 S21: 0.3315 S22: -0.0693 S23: -1.1114 REMARK 3 S31: -0.0054 S32: 0.0285 S33: -0.0009 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 339 B 339 REMARK 3 ORIGIN FOR THE GROUP (A): -53.5490 73.4890 -14.5250 REMARK 3 T TENSOR REMARK 3 T11: 0.4087 T22: 0.2910 REMARK 3 T33: 0.3725 T12: 0.0037 REMARK 3 T13: 0.0539 T23: -0.0691 REMARK 3 L TENSOR REMARK 3 L11: 12.2710 L22: 0.0065 REMARK 3 L33: 9.4312 L12: -0.2629 REMARK 3 L13: 10.7565 L23: -0.2297 REMARK 3 S TENSOR REMARK 3 S11: -0.0190 S12: -0.2791 S13: 0.0248 REMARK 3 S21: 0.0006 S22: -0.0093 S23: 0.0085 REMARK 3 S31: 0.0091 S32: -0.2586 S33: 0.0283 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 12 REMARK 3 RESIDUE RANGE : A 117 A 335 REMARK 3 ORIGIN FOR THE GROUP (A): -19.6650 79.3810 10.5730 REMARK 3 T TENSOR REMARK 3 T11: 0.0593 T22: 0.0619 REMARK 3 T33: 0.0346 T12: -0.0084 REMARK 3 T13: 0.0009 T23: -0.0187 REMARK 3 L TENSOR REMARK 3 L11: 0.8693 L22: 1.2974 REMARK 3 L33: 1.1221 L12: 0.5154 REMARK 3 L13: 0.6436 L23: 0.2446 REMARK 3 S TENSOR REMARK 3 S11: 0.0035 S12: -0.0237 S13: -0.0710 REMARK 3 S21: 0.1000 S22: 0.0715 S23: -0.1569 REMARK 3 S31: -0.0695 S32: 0.1346 S33: -0.0751 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 13 A 116 REMARK 3 ORIGIN FOR THE GROUP (A): -40.2680 93.2240 2.8070 REMARK 3 T TENSOR REMARK 3 T11: 0.1896 T22: 0.1301 REMARK 3 T33: 0.0839 T12: 0.0318 REMARK 3 T13: -0.0067 T23: 0.0082 REMARK 3 L TENSOR REMARK 3 L11: 2.3638 L22: 0.5364 REMARK 3 L33: 1.8141 L12: -0.6924 REMARK 3 L13: -1.5109 L23: 0.8455 REMARK 3 S TENSOR REMARK 3 S11: 0.0290 S12: -0.0934 S13: 0.2649 REMARK 3 S21: -0.0653 S22: 0.0248 S23: 0.0369 REMARK 3 S31: -0.2813 S32: -0.1119 S33: -0.0539 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 12 REMARK 3 RESIDUE RANGE : B 117 B 335 REMARK 3 ORIGIN FOR THE GROUP (A): -43.7110 55.1380 -10.4270 REMARK 3 T TENSOR REMARK 3 T11: 0.0615 T22: 0.0681 REMARK 3 T33: 0.0256 T12: -0.0064 REMARK 3 T13: -0.0255 T23: 0.0023 REMARK 3 L TENSOR REMARK 3 L11: 1.2979 L22: 0.9269 REMARK 3 L33: 0.7217 L12: 0.4503 REMARK 3 L13: 0.0878 L23: 0.6262 REMARK 3 S TENSOR REMARK 3 S11: 0.0548 S12: 0.1273 S13: -0.1420 REMARK 3 S21: -0.0303 S22: 0.0050 S23: -0.0571 REMARK 3 S31: 0.0814 S32: -0.0505 S33: -0.0599 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 13 B 116 REMARK 3 ORIGIN FOR THE GROUP (A): -57.9010 75.7060 -2.7690 REMARK 3 T TENSOR REMARK 3 T11: 0.1553 T22: 0.2581 REMARK 3 T33: 0.0948 T12: 0.0784 REMARK 3 T13: 0.0033 T23: -0.0062 REMARK 3 L TENSOR REMARK 3 L11: 0.3439 L22: 2.6017 REMARK 3 L33: 2.4761 L12: -0.6297 REMARK 3 L13: 0.8280 L23: -2.0099 REMARK 3 S TENSOR REMARK 3 S11: 0.0108 S12: -0.1156 S13: 0.0337 REMARK 3 S21: -0.0236 S22: 0.0575 S23: 0.2816 REMARK 3 S31: -0.1619 S32: -0.4406 S33: -0.0684 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES: RESIDUAL ONLY REMARK 4 REMARK 4 3JUH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1000055174. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JAN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.811 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 72782 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 39.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.5100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2M SODIUM CITRATE, 2MM AMPPNP, 4MM REMARK 280 MAGNESIUM CHLORIDE, 0.62MM PEPTIDE RRRADDSDDDDD, PH 6.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.23350 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 94.85025 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 31.61675 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG B 275 O HOH B 550 2.03 REMARK 500 O LYS A 279 O HOH A 484 2.05 REMARK 500 ND2 ASN A 238 O HOH A 448 2.08 REMARK 500 O HOH A 540 O HOH A 544 2.10 REMARK 500 O GLN A 123 O HOH A 541 2.15 REMARK 500 O ILE A 94 O HOH A 346 2.15 REMARK 500 OH TYR B 239 O HOH B 428 2.18 REMARK 500 OE1 GLU B 320 O HOH B 389 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE2 GLN A 40 O GLY B 335 4365 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 147 CB CYS A 147 SG -0.097 REMARK 500 LEU A 213 CG LEU A 213 CD1 0.245 REMARK 500 GLU B 320 CD GLU B 320 OE1 0.072 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 124 CA - CB - CG ANGL. DEV. = 14.5 DEGREES REMARK 500 LEU A 163 CB - CG - CD2 ANGL. DEV. = 10.3 DEGREES REMARK 500 ARG A 172 NE - CZ - NH1 ANGL. DEV. = 3.8 DEGREES REMARK 500 LEU A 213 CB - CG - CD1 ANGL. DEV. = 10.6 DEGREES REMARK 500 ASP A 308 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ARG A 316 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES REMARK 500 VAL B 11 CG1 - CB - CG2 ANGL. DEV. = 13.6 DEGREES REMARK 500 ARG B 89 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG B 89 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 ASP B 132 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ARG B 134 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 ASP B 175 CB - CG - OD2 ANGL. DEV. = -6.5 DEGREES REMARK 500 ARG B 191 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 MET B 215 CG - SD - CE ANGL. DEV. = 11.6 DEGREES REMARK 500 ARG B 280 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG B 312 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG B 312 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 37 2.52 -67.41 REMARK 500 PRO A 72 159.45 -46.58 REMARK 500 VAL A 73 150.46 154.99 REMARK 500 ASN A 118 26.31 -35.51 REMARK 500 TYR A 125 -31.99 -32.04 REMARK 500 ASP A 156 40.46 -154.76 REMARK 500 ASP A 175 71.57 60.62 REMARK 500 ALA A 193 -177.46 70.33 REMARK 500 MET A 208 52.00 -96.20 REMARK 500 HIS A 234 72.05 -104.81 REMARK 500 SER B 51 147.20 -173.43 REMARK 500 LYS B 74 106.93 -45.57 REMARK 500 VAL B 105 -76.23 -88.51 REMARK 500 ASN B 117 122.77 -33.86 REMARK 500 ARG B 155 -1.13 78.84 REMARK 500 ASP B 156 49.79 -142.09 REMARK 500 ASP B 175 71.26 51.46 REMARK 500 ARG B 191 34.00 -78.50 REMARK 500 ALA B 193 138.80 56.07 REMARK 500 ASP B 210 -149.35 -154.19 REMARK 500 MET B 334 -74.85 -101.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 117 ASN A 118 146.28 REMARK 500 ASN B 117 ASN B 118 -141.30 REMARK 500 ASN B 118 THR B 119 -143.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP A 339 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 340 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 337 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP B 339 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 340 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3H30 RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT THE TWO POINT MUTATIONS AT POSITIONS 66 REMARK 900 AND 163 AND IN COMPLEX WITH THE INHIBITOR 5,6-DICHLORO-1-BETA-D- REMARK 900 RIBOFURANOSYL-1H-BENZIMIDAZOLE REMARK 900 RELATED ID: 3FWQ RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT THE TWO POINT MUTATIONS AT POSITIONS 66 REMARK 900 AND 163 IN AN INACTIVE CONFORMATION REMARK 900 RELATED ID: 1JWH RELATED DB: PDB REMARK 900 THE CK2 HOLOENZYME, I.E. THE SAME PROTEIN IN COMPLEX WITH THE REMARK 900 REGULATORY SUBUNIT CK2BETA REMARK 900 RELATED ID: 2PVR RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT THE TWO POINT MUTATIONS AT POSITIONS 66 REMARK 900 AND 163 IN COMPLEX WITH THE NON-HYDROLYSABLE ATP ANALOGUE ADENYLYL REMARK 900 IMIDO DIPHOSPHATE AND WITH TWO SULFATE IONS REMARK 900 RELATED ID: 1LP4 RELATED DB: PDB REMARK 900 THE ORTHOLOG PROTEIN FROM MAIZE IN COMPLEX WITH ADENYLYL IMIDO REMARK 900 DIPHOSPHATE AND TWO MAGNESIUM IONS DBREF 3JUH A 1 335 UNP P68400 CSK21_HUMAN 1 335 DBREF 3JUH B 1 335 UNP P68400 CSK21_HUMAN 1 335 SEQADV 3JUH ALA A 66 UNP P68400 VAL 66 ENGINEERED MUTATION SEQADV 3JUH LEU A 163 UNP P68400 MET 163 ENGINEERED MUTATION SEQADV 3JUH ALA B 66 UNP P68400 VAL 66 ENGINEERED MUTATION SEQADV 3JUH LEU B 163 UNP P68400 MET 163 ENGINEERED MUTATION SEQRES 1 A 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 A 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 A 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 A 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 A 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 A 335 ALA VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 A 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 A 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 A 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 A 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 A 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 A 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 A 335 VAL LYS PRO HIS ASN VAL LEU ILE ASP HIS GLU HIS ARG SEQRES 14 A 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 A 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 A 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 A 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 A 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 A 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 A 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 A 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 A 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 A 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 A 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 A 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 A 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY SEQRES 1 B 335 MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR THR SEQRES 2 B 335 ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP TYR SEQRES 3 B 335 GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP TYR SEQRES 4 B 335 GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER GLU SEQRES 5 B 335 VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS VAL SEQRES 6 B 335 ALA VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS ILE SEQRES 7 B 335 LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY GLY SEQRES 8 B 335 PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP PRO SEQRES 9 B 335 VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL ASN SEQRES 10 B 335 ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR ASP SEQRES 11 B 335 TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS ALA SEQRES 12 B 335 LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG ASP SEQRES 13 B 335 VAL LYS PRO HIS ASN VAL LEU ILE ASP HIS GLU HIS ARG SEQRES 14 B 335 LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE TYR SEQRES 15 B 335 HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER ARG SEQRES 16 B 335 TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN MET SEQRES 17 B 335 TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS MET SEQRES 18 B 335 LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE HIS SEQRES 19 B 335 GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA LYS SEQRES 20 B 335 VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP LYS SEQRES 21 B 335 TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE LEU SEQRES 22 B 335 GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL HIS SEQRES 23 B 335 SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU ASP SEQRES 24 B 335 PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER ARG SEQRES 25 B 335 LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE TYR SEQRES 26 B 335 THR VAL VAL LYS ASP GLN ALA ARG MET GLY HET CL A 336 1 HET CL A 337 1 HET CL A 338 1 HET ANP A 339 31 HET GOL A 340 6 HET CL B 336 1 HET CL B 337 1 HET CL B 338 1 HET ANP B 339 31 HET GOL B 340 6 HETNAM CL CHLORIDE ION HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 CL 6(CL 1-) FORMUL 6 ANP 2(C10 H17 N6 O12 P3) FORMUL 7 GOL 2(C3 H8 O3) FORMUL 13 HOH *518(H2 O) HELIX 1 1 ASP A 14 ARG A 19 1 6 HELIX 2 2 PRO A 20 ASP A 25 1 6 HELIX 3 3 TYR A 26 HIS A 29 5 4 HELIX 4 4 ASN A 35 ASP A 37 5 3 HELIX 5 5 LYS A 74 ARG A 89 1 16 HELIX 6 6 ASP A 120 TYR A 125 1 6 HELIX 7 7 THR A 129 MET A 150 1 22 HELIX 8 8 LYS A 158 HIS A 160 5 3 HELIX 9 9 SER A 194 LYS A 198 5 5 HELIX 10 10 GLY A 199 VAL A 204 1 6 HELIX 11 11 TYR A 211 ARG A 228 1 18 HELIX 12 12 ASP A 237 GLY A 250 1 14 HELIX 13 13 THR A 251 TYR A 261 1 11 HELIX 14 14 ASP A 266 GLY A 274 1 9 HELIX 15 15 ARG A 280 VAL A 285 5 6 HELIX 16 16 ASN A 289 VAL A 293 5 5 HELIX 17 17 SER A 294 LEU A 305 1 12 HELIX 18 18 ASP A 308 ARG A 312 5 5 HELIX 19 19 THR A 314 GLU A 320 1 7 HELIX 20 20 HIS A 321 TYR A 325 5 5 HELIX 21 21 THR A 326 ASP A 330 5 5 HELIX 22 22 PRO B 20 ASP B 25 1 6 HELIX 23 23 ASN B 35 ASP B 37 5 3 HELIX 24 24 LYS B 74 ARG B 89 1 16 HELIX 25 25 ASP B 120 LEU B 128 5 9 HELIX 26 26 THR B 129 MET B 150 1 22 HELIX 27 27 LYS B 158 HIS B 160 5 3 HELIX 28 28 HIS B 166 ARG B 169 5 4 HELIX 29 29 SER B 194 LYS B 198 5 5 HELIX 30 30 GLY B 199 VAL B 204 1 6 HELIX 31 31 TYR B 211 ARG B 228 1 18 HELIX 32 32 ASP B 237 GLY B 250 1 14 HELIX 33 33 THR B 251 TYR B 261 1 11 HELIX 34 34 ASP B 266 GLY B 274 1 9 HELIX 35 35 ARG B 280 VAL B 285 5 6 HELIX 36 36 ASN B 289 VAL B 293 5 5 HELIX 37 37 SER B 294 LEU B 305 1 12 HELIX 38 38 THR B 314 GLU B 320 1 7 HELIX 39 39 HIS B 321 TYR B 325 5 5 HELIX 40 40 THR B 326 ASP B 330 5 5 SHEET 1 A 5 TYR A 39 ARG A 47 0 SHEET 2 A 5 SER A 51 ASN A 58 -1 O GLU A 55 N VAL A 42 SHEET 3 A 5 GLU A 63 LEU A 70 -1 O ILE A 69 N GLU A 52 SHEET 4 A 5 PRO A 109 GLU A 114 -1 O PHE A 113 N ALA A 66 SHEET 5 A 5 LEU A 97 LYS A 102 -1 N VAL A 101 O ALA A 110 SHEET 1 B 2 ILE A 152 MET A 153 0 SHEET 2 B 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 C 2 VAL A 162 ASP A 165 0 SHEET 2 C 2 LYS A 170 LEU A 173 -1 O LYS A 170 N ASP A 165 SHEET 1 D 5 TYR B 39 ARG B 47 0 SHEET 2 D 5 SER B 51 ASN B 58 -1 O GLU B 55 N VAL B 42 SHEET 3 D 5 LYS B 64 LEU B 70 -1 O VAL B 65 N ALA B 56 SHEET 4 D 5 PRO B 109 GLU B 114 -1 O PHE B 113 N ALA B 66 SHEET 5 D 5 LEU B 97 LYS B 102 -1 N ALA B 98 O VAL B 112 SHEET 1 E 2 ILE B 152 MET B 153 0 SHEET 2 E 2 GLU B 180 PHE B 181 -1 O GLU B 180 N MET B 153 SHEET 1 F 2 VAL B 162 ASP B 165 0 SHEET 2 F 2 LYS B 170 LEU B 173 -1 O ARG B 172 N LEU B 163 CISPEP 1 GLU A 230 PRO A 231 0 -11.95 CISPEP 2 GLU B 230 PRO B 231 0 -6.13 SITE 1 AC1 3 VAL A 11 HIS A 148 ALA A 315 SITE 1 AC2 2 ARG A 155 GLU A 180 SITE 1 AC3 2 PRO A 159 HIS A 160 SITE 1 AC4 19 LEU A 45 ARG A 47 GLY A 48 TYR A 50 SITE 2 AC4 19 SER A 51 VAL A 53 ALA A 66 LYS A 68 SITE 3 AC4 19 GLU A 114 VAL A 116 ASN A 118 HIS A 160 SITE 4 AC4 19 LEU A 163 ASP A 175 HOH A 370 HOH A 403 SITE 5 AC4 19 HOH A 503 HOH A 559 HOH A 576 SITE 1 AC5 5 ARG A 21 LEU A 41 ASP A 103 PRO A 104 SITE 2 AC5 5 HOH A 432 SITE 1 AC6 3 HIS B 148 ALA B 315 HOH B 350 SITE 1 AC7 2 ARG B 155 ASN B 189 SITE 1 AC8 6 LYS B 68 PHE B 113 ASP B 175 ANP B 339 SITE 2 AC8 6 HOH B 353 HOH B 553 SITE 1 AC9 17 GLY B 46 ARG B 47 GLY B 48 SER B 51 SITE 2 AC9 17 VAL B 53 ALA B 66 LYS B 68 ILE B 95 SITE 3 AC9 17 PHE B 113 GLU B 114 VAL B 116 ASN B 118 SITE 4 AC9 17 ASP B 120 HIS B 160 LEU B 163 ASP B 175 SITE 5 AC9 17 CL B 338 SITE 1 BC1 5 PRO B 20 ARG B 21 LEU B 41 PRO B 104 SITE 2 BC1 5 HOH B 347 CRYST1 71.368 71.368 126.467 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014012 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014012 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007907 0.00000